Allergy

Autoimmune Diseases

Biosimilars

COVID-19

Cannabidiol (CBD)

Cardiology

Compounding

Continuous Glucose Monitoring

Dermatology

Diabetes

Digestive Health

Endocrinology

Eye Health

Generics

Headache and Migraine

Immunization

Infectious Disease

Influenza

Insulin Management

Medical Devices

Mental and Behavioral Health

Neurology

Obesity Management

Oncology

Nonopioid Pain Management

Pain Management

Pediatrics

Pneumococcal

Public Health

Rare Diseases

Respiratory

Rheumatology

Shingles

Substance Use Disorder

Technology and Data

Veterinary Pharmacy 

Women's Health

News

FDA Updates

Law and Advocacy

Technology Trends

Viewpoints

All News

Media

In-Depth Insights

Pharmacist View

Script-Ed

Expert Interviews

Podcasts

Conferences

Conference Coverage

Conference Listing

Resources

Disease Awareness 

White Board Video

American Pharmacists Month

CME/CE

Partners

Publications

Drug Topics Journal

Total Pharmacy Journal

Submission of Articles

Events

Virtual Events

Total Pharmacy Solutions Summit

Business

Business Strategies

Patient Services

Pharmacy Inventory

Law and Regulations

All Business News

Practice Type

Independent Pharmacy

Chain Pharmacy

Specialty Pharmacy

Health System Pharmacy

Pharmacy Technicians

Subscribe

Articles

Efsitora demonstrates noninferior reductions in hemoglobin A1c and similar rates of patients with an A1c of less than 7% compared with common daily insulin.

Once Weekly Insulin Efsitora Alfa Shows Similar Efficacy to Daily Insulin

The therapy is now the first and only oral on demand treatment option for the condition.

FDA Approves Sebetralstat for Hereditary Angioedema

Researchers determined the impact COVID-19 interventions had on Dannish children’s incidence of RSV, influenza, and invasive pneumococcal disease. 

Increased COVID-19 Testing Skewed Understanding of Respiratory Disease Trends

This year’s conference is taking place from July 10 to 13 in Nashville, Tennessee.

Meeting Preview: McKesson ideaShare 2025

Drug Topics connects pharmacists across retail, health system, and specialty practice with clinical updates, pharmacy trends, and regulatory news.

About

Advertise

Editorial

Editorial Board

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Drug Topics – Pharmacy News and Multisetting Practice Insights

Facebook

LinkedIn

Spotlight

APhA Annual Meeting

AAP Annual Meeting

NCPDP Annual Conference

1rem

Lucio Volino, PharmD, FAPhA, RUCIF, NCNTT, and Lauren Angelo, PharmD, MBA, discuss how recent CDC recommendations have lowered the age for routine pneumococcal vaccination from 65 to 50 years old, explore the complexities of vaccine selection and sequencing among different pneumococcal vaccines (PCV15, PCV20, PCV21, and PPSV23), and provide practical guidance for pharmacists on identifying eligible patients, overcoming vaccination barriers, and implementing systematic approaches to improve pneumococcal vaccination rates in adult populations.

Evolving Perspectives on Pneumococcal Vaccination Across Adult Populations 

A panel of experts discuss current standard of care and treatment options for treatment-resistant depression.

Exploring the Treatment Landscape for Treatment-Resistant Depression 

Proper Injection Technique Ensures Positive Outcomes Among Patients With Diabetes

Current treatment and patient education strategies are discussed by Jerry Meece, RPh, CDCES, FACA, FADCES, and Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP.

Optimizing Treatment Strategies for Diabetes

An expert panel discusses the importance of accessibility, patient engagement and adherence to receiving yearly influenza vaccines.

The Evolving Landscape of Influenza Immunizations

A panel of experts discuss opioid abuse in today’s treatment landscape for pain management and the ways to counteract it, focusing on naloxone.

Opioid Abuse and the Role of Naloxone

Recommendations for counseling and managing patients’ lipid levels with newer treatments as prophylaxis against cardiovascular events.

Multidisciplinary Lipid Management for Prevention of Cardiovascular Risks